Investment analysts at Robert W. Baird dropped their target price on shares of Allscripts Healthcare Solutions (NASDAQ: MDRX) Allscripts Healthcare Solutions traded down 0.22% on Friday, hitting $9.12. Allscripts Healthcare Solutions has a 1-year low of $8.84 and a 1-year high of $21.66. The company has a market cap of $1.558 billion and a price-to-earnings ratio of 34.10. Allscripts Healthcare Solutions last released its earnings data on Thursday, November 8th. The company reported $0.23 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.22 by $0.01. The company had revenue of $361.00 million for the quarter, compared to the consensus estimate of $376.97 million. During the same quarter in 2011, the company posted $0.25 earnings per share. The company?s quarterly revenue was down 2.8% on a year-over-year basis. Analysts expect that Allscripts Healthcare Solutions will post $0.72 EPS for the current fiscal year.
Other equities research analysts have also recently issued reports about the stock. Analysts at Jefferies Group cut their price target on shares of Allscripts Healthcare Solutions from $13.00 to $10.00 in a research note to investors on Friday. They now have a ?hold? rating on the stock. Separately, analysts at Argus downgraded shares of Allscripts Healthcare Solutions from a ?buy? rating to a ?hold? rating in a research note to investors on Friday. Finally, analysts at Leerink Swann reiterated a ?market perform? rating on shares of Allscripts Healthcare Solutions in a research note to investors on Thursday. Allscripts Healthcare Solutions, Inc. (Allscripts) is a provider of clinical, financial, connectivity and information solutions and related professional services to hospitals, physicians and post-acute organizations.